Document Detail


Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention.
MedLine Citation:
PMID:  21357797     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Quality-assurance initiatives encourage adherence to evidenced-based guidelines based on a consideration of treatment benefit. We examined older persons' willingness to take medication for primary cardiovascular disease prevention according to benefits and harms.
METHODS: In-person interviews were performed with 356 community-living older persons. Participants were asked about their willingness to take medication for primary prevention of myocardial infarction (MI) with varying benefits in terms of absolute 5-year risk reduction and varying harms in terms of type and severity of adverse effects.
RESULTS: Most (88%) would take medication, providing an absolute benefit of 6 fewer persons with MI out of 100, approximating the average risk reduction of currently available medications. Of participants who would not take it, 17% changed their preference if the absolute benefit was increased to 10 fewer persons with MI, and, of participants who would take it, 82% remained willing if the absolute benefit was decreased to 3 fewer persons with MI. In contrast, large proportions (48%-69%) were unwilling or uncertain about taking medication with average benefit causing mild fatigue, nausea, or fuzzy thinking, and only 3% would take medication with adverse effects severe enough to affect functioning.
CONCLUSIONS: Older persons' willingness to take medication for primary cardiovascular disease prevention is relatively insensitive to its benefit but highly sensitive to its adverse effects. These results suggest that clinical guidelines and decisions about prescribing these medications to older persons need to place emphasis on both benefits and harms.
Authors:
Terri R Fried; Mary E Tinetti; Virginia Towle; John R O'Leary; Lynne Iannone
Related Documents :
17656727 - A descriptive study of morbidity and mortality conferences and their conformity to medi...
21471477 - The social cost of adverse medical events, and what we can do about it.
11234337 - Quinine (cinchona) and the incurable malaria: india c. 1900-1930s.
18978257 - The jaipur foot.
16761887 - The combitube, self-inflating bulb, and colorimetric carbon dioxide detector to advance...
18303147 - Accuracy of a provincial prescription database for assessing medication adherence in he...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-02-28
Journal Detail:
Title:  Archives of internal medicine     Volume:  171     ISSN:  1538-3679     ISO Abbreviation:  Arch. Intern. Med.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-05-24     Completed Date:  2011-07-26     Revised Date:  2012-05-23    
Medline Journal Info:
Nlm Unique ID:  0372440     Medline TA:  Arch Intern Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  923-8     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA. terri.fried@yale.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Aspirin / administration & dosage,  adverse effects
Cardiotonic Agents / administration & dosage,  adverse effects
Cardiovascular Diseases / prevention & control
Female
Health Knowledge, Attitudes, Practice*
Humans
Interviews as Topic
Male
Myocardial Infarction / prevention & control*
Patient Compliance
Patient Participation*
Patient Selection
Pharmaceutical Preparations / administration & dosage,  adverse effects*
Primary Prevention / methods*
Questionnaires
Risk Assessment
Grant Support
ID/Acronym/Agency:
K24 AG028443/AG/NIA NIH HHS; K24 AG028443-01A2/AG/NIA NIH HHS; K24 AG028443-05/AG/NIA NIH HHS; P30AG21342/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Cardiotonic Agents; 0/Pharmaceutical Preparations; 50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fasting indicators of insulin sensitivity: effects of ethnicity and pubertal status.
Next Document:  Decreased Antibiotic Utilization After Implementation of a Guideline for Inpatient Cellulitis and Cu...